GAMBARAN KEJADIAN KANKER PROSTAT PADA PENDERITA DIABETES MELLITUS DI RSUP H. ADAM MALIK MEDAN
Abstract
According to Kemenkes RI, in 2013, the number of prostate cancer patient is 0.2% or approximately 25,012 patients. Prostate cancer is a malignancy in the prostatic gland and more than 95% of prostate cancer is adenocarcinoma, the other 5% is transitional cell and neuroendocrine carcinoma or sarcoma. Up to now, the etiology of prostate cancer is still unknown, but it involves multifactor and genetic mutations. This study is a descriptive study design with a retrospective cross sectional in the Urology Division of the Department of Surgery, General Hospital of H. Adam Malik Medan during period January to December 2014. From this study we found about 261 patients of Diabetes Mellitus who visited surgery, but only as many as 41 people (15.7%) performed prostate biopsy, and of the 41 people who had the most prostate cancer were 24 people (58.5%). The highest age range was 70-74 years (37.5%), with PSA values more than 50 ng / ml as much (33.3%), and the highest Gleason score in the range of 5-6 (50%)
References
Abouassaly, R., Thompson, I.M., Platz, E.A. & Klein, E.A. 2012. Epidemiology, Etiology, and Prevention of Prostate Cancer. dalam Wein, A., Kavoussi, L., Novick, A., Partin, A. & Peters, C. (Eds.) Campbell-Walsh Urology. Philadelphia: Elsevier Saunders.
Bickley, L. 2009. Guide to Physical Examination and History Taking, Philadelphia: Lippincott Williams & Walkins.
Cho, H.N., Whiting, D., Guariguata, L. 2013. International Diabetes Federation Atlas. pp. 160-6.
Chung, B.I., Sommer, G. & Brooks, J.D. 2012. Anatomy of the Lower Urinary Tract and Male Genitalia. dalam Wein, A., Kavoussi, L., Novick, A., Partin, A. & Peters, C. (Eds.) Campbell-Walsh Urology. Philadelphia: Elsevier Saunders.
Drake, R.L., Volg, W. & Mitchell, A.W.M. 2007. Pelvis and Perineum: Gray's Anatomy for Students. Spain: Elsevier Churchill Livingstone.
Eble, J.N., Sauter, G., Epstein, J.I. & Sesterhenn, I. 2004. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs, Lyon, France, IARC Press.
Epstein, J.I. 2012. Pathology of Prostatic Neoplasia. dalam Wein, A., Kavoussi, L., Novick, A., Partin, A. & Peters, C. (Eds.) Campbell-Walsh Urology. Philadelphia: Elsevier Saunders.
Gallagher, E.J. & Leroith, D. 2010. The proliferating Role of Insulin and Insulin-like Growth Factors in Cancer. Trends Endocrinol Metab, 21, pp. 610-8.
Hsieh, M.C., Lee, T.C., Cheng, S.M., Tu, S.T., Yen, M.H. & Tseng, C.H. 2012. The Influence of Type 2 Diabetes and Glucose-Lowering Therapies on Cancer Risk in the Taiwanese. Exp Diabetes Res.
Kasper, J.S., Liu, Y. & Giovannucci, E. 2009. Diabetes Mellitus and Risk of Prostate Cancer in the Health Professionals Follow-up Study. Int J Cancer, 124, pp. 1398-403.
Kementerian Kesehatan RI. 2015. Stop Kanker. Jakarta: Pusat Data dan Informasi, 6-1.
Loeb, S. & Carter, H.B. 2012. Early Detection, Diagnosis, and Staging of Prostate Cancer. dalam Wein, A., Kavoussi, L., Novick, A., Partin, A. & Peters, C. (Eds.) Campbell-Walsh Urology. Philadelphia: Elsevier Saunders.
Long, X.J., Lin, S., Sun, Y.N. & Zheng, Z.F. 2012. Diabetes Mellitus and Prostate Cancer Risk in Asian Countries: a Meta-Analysis. Asian Pac J Cancer Prev, 13, pp. 4097-100.
Presti, J.C., Kane, C.J., Sinohara, K. & Caroll, P.R. 2008. Neoplasms of The Prostate Gland. dalam Tanagho, E. & Mc Aninch, J.W. (Eds) Smith's General Urology. 17th. New York: Mc Graw Hill Siegel, R., Ma, J., Zou, Z. & Jemal, A. 2014. Cancer Statistics, 2014. CA Cancer J Clin, 64, pp. 9-29.
Waters, K.M., Henderson, B.E., Stram, D.O., Wan, P., Kolonel, L.N. & Haiman, C.A. 2009. Association of Diabetes with Prostate Cancer Risk in the Multiethnic Cohort. Am J Epidemiol, 169, pp. 937-45.
Xu, H., Mao, S.H., Ding, G.X., Ding, Q. & Jiang, H.W. 2013. Diabetes Mellitus Reduces Prostate Cancer Risk no Function of Age at Diagnosis or Duration of Disease. Asian Pac J Cancer Prev, 14, pp. 441-7.
